EMA advisors at the Committee for Medicinal Products for Human Use (CHMP) recommended Sandoz’s adalimumab Humira biosimilar under three brand names – Halimatoz, Hefiya and Hyrimoz. The firm ...

The reference adalimumab (Humira) is available in its original lower-concentration formulation and a high-concentration, citrate-free formulation. Some adalimumab biosimilars use citrate as a ...

This week has seen the launch of new and lower-priced biosimilars to AbbVie’s Humira (adalimumab), many months after Amgen’s Amjevita (adalimumab-atto) was released in the US in January.

The patient was receiving mesalazine and 6-mercaptopurine and, 2 months before admission, had stopped a 4-month therapy course with the biologic agent adalimumab for treatment of Crohn's disease.

The anti-inflammatory injection, also known as adalimumab, lost its U.S. market ... its dominance with a 96% market share as of February, Humira's market leadership came under threat in 2024 ...

1 Adalimumab (Humira),, a tumor necrosis factor (TNF)-α inhibitor, was approved by the FDA in 2015 to treat HS. 1 Prior to its approval, patients with HS relied on surgery to remove the skin ...

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.

The anti-inflammatory injection, also known as adalimumab, lost its U.S. market ... After accounting for over a third of its revenue in 2022, Humira's contribution to AbbVie's (ABBV) topline ...

Opens in a new tab or window Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients with hidradenitis suppurativa, post hoc ...

Read the Medication Guide and Instructions for Use provided by your pharmacist before you start using adalimumab and each time you get a refill. Ask your health care professional how to prepare ...

#Data provided for the iv. administration only. ADM: Adalimumab; AUC 0-∞: Area under the plasma concentration-time curve from time zero to infinity; CL/F: Apparent total clearance of the drug ...